JPS5188631U - - Google Patents
Info
- Publication number
- JPS5188631U JPS5188631U JP624675U JP624675U JPS5188631U JP S5188631 U JPS5188631 U JP S5188631U JP 624675 U JP624675 U JP 624675U JP 624675 U JP624675 U JP 624675U JP S5188631 U JPS5188631 U JP S5188631U
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Replacing, Conveying, And Pick-Finding For Filamentary Materials (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP624675U JPS5188631U (enExample) | 1975-01-10 | 1975-01-10 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP624675U JPS5188631U (enExample) | 1975-01-10 | 1975-01-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5188631U true JPS5188631U (enExample) | 1976-07-15 |
Family
ID=28070339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP624675U Pending JPS5188631U (enExample) | 1975-01-10 | 1975-01-10 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5188631U (enExample) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7291637B2 (en) | 2001-12-19 | 2007-11-06 | Bristol-Myers Squibb Company | Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function |
| US7470797B2 (en) | 2001-06-20 | 2008-12-30 | Bristol-Myers Squibb Company | Fused heterocyclic imido and amido compounds |
| US11931354B2 (en) | 2013-04-09 | 2024-03-19 | Lixte Biotechnology, Inc. | Formulations of oxabicycloheptanes and oxabicycloheptenes |
| US12168008B2 (en) | 2016-12-08 | 2024-12-17 | Lixte Biotechnology, Inc. | Oxabicycloheptanes for modulation of immune response |
-
1975
- 1975-01-10 JP JP624675U patent/JPS5188631U/ja active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7517904B2 (en) | 2000-09-19 | 2009-04-14 | Bristol-Myers Squibb Company | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| US7470797B2 (en) | 2001-06-20 | 2008-12-30 | Bristol-Myers Squibb Company | Fused heterocyclic imido and amido compounds |
| US7291637B2 (en) | 2001-12-19 | 2007-11-06 | Bristol-Myers Squibb Company | Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function |
| US7342034B2 (en) | 2001-12-19 | 2008-03-11 | Bristol-Myers Squibb Company | Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function |
| US11931354B2 (en) | 2013-04-09 | 2024-03-19 | Lixte Biotechnology, Inc. | Formulations of oxabicycloheptanes and oxabicycloheptenes |
| US12168008B2 (en) | 2016-12-08 | 2024-12-17 | Lixte Biotechnology, Inc. | Oxabicycloheptanes for modulation of immune response |